Inventor
HUNT HAZEL
GB51 patents
⚠️ This page may combine multiple inventors who share the name “HUNT HAZEL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CORCEPT THERAPEUTICS INC
46 patentsUS10213414B2Feb 26, 2019
Glucocorticoid receptor modulators to treat pancreatic cancer
CORCEPT THERAPEUTICS INC38 citations97
US10117852B2Nov 6, 2018
Glucocorticoid receptor modulators to treat pancreatic cancer
CORCEPT THERAPEUTICS INC35 citations97
US10047082B2Aug 14, 2018
Octahydro fused azadecalin glucocorticoid receptor modulators
CORCEPT THERAPEUTICS INC40 citations97
US9956216B2May 1, 2018
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
CORCEPT THERAPEUTICS INC40 citations97
US9943505B2Apr 17, 2018
Glucocorticoid receptor modulators to treat pancreatic cancer
CORCEPT THERAPEUTICS INC47 citations97
US9707223B2Jul 18, 2017
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
CORCEPT THERAPEUTICS INC44 citations97
US9273047B2Mar 1, 2016
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
CORCEPT THERAPEUTICS INC66 citations97
US8859774B2Oct 14, 2014
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
CORCEPT THERAPEUTICS INC67 citations97
US10973813B2Apr 13, 2021
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
CORCEPT THERAPEUTICS INC16 citations94
US10898478B2Jan 26, 2021
Glucocorticoid receptor modulators to treat cervical cancer
CORCEPT THERAPEUTICS INC15 citations94
US10568880B2Feb 25, 2020
Glucocorticoid receptor modulators to treat cervical cancer
CORCEPT THERAPEUTICS INC22 citations94
US10456392B2Oct 29, 2019
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
CORCEPT THERAPEUTICS INC25 citations94
US10413540B2Sep 17, 2019
Glucocorticoid receptor modulators to treat cervical cancer
CORCEPT THERAPEUTICS INC25 citations94
US10787449B2Sep 29, 2020
Octahydro fused azadecalin glucocorticoid receptor modulators
CORCEPT THERAPEUTICS INC11 citations93
US10646474B2May 12, 2020
Glucocorticoid receptor modulators to treat pancreatic cancer
CORCEPT THERAPEUTICS INC12 citations93
US10323034B2Jun 18, 2019
Octahydro fused azadecalin glucocorticoid receptor modulators
CORCEPT THERAPEUTICS INC20 citations93
US10828280B2Nov 10, 2020
Glucocorticoid receptor modulators to treat pancreatic cancer
CORCEPT THERAPEUTICS INC9 citations92
US10449178B2Oct 22, 2019
Glucocorticoid receptor modulators to treat pancreatic cancer
CORCEPT THERAPEUTICS INC10 citations92
US10238659B2Mar 26, 2019
Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonists
CORCEPT THERAPEUTICS INC13 citations91
US7678813B2Mar 16, 2010
Azadecalin Glucocorticoid receptor modulators
CORCEPT THERAPEUTICS INC42 citations91
US11660295B2May 30, 2023
Glucocorticoid receptor modulators to treat cervical cancer
CORCEPT THERAPEUTICS INC5 citations86
US11648245B2May 16, 2023
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
CORCEPT THERAPEUTICS INC4 citations85
US11576907B2Feb 14, 2023
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
CORCEPT THERAPEUTICS INC6 citations85
US11560379B2Jan 24, 2023
Octahydro fused azadecalin glucocorticoid receptor modulators
CORCEPT THERAPEUTICS INC6 citations85
US11370789B2Jun 28, 2022
Octahydro fused azadecalin glucocorticoid receptor modulators
CORCEPT THERAPEUTICS INC8 citations85
US10980797B2Apr 20, 2021
Use of glucocorticoid receptor modulators to potentiate checkpoint inhibitors
CORCEPT THERAPEUTICS INC6 citations84
US10881660B2Jan 5, 2021
Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonists
CORCEPT THERAPEUTICS INC9 citations84
US11285145B2Mar 29, 2022
Concomitant administration of glucocorticoid receptor modulator relacorilant and paclitaxel, a dual substrate of CYP2C8 and CYP3A4
CORCEPT THERAPEUTICS INC5 citations81
US12285425B2Apr 29, 2025
Glucocorticoid receptor modulators to treat cervical cancer
CORCEPT THERAPEUTICS INC1 citations75
US11642331B2May 9, 2023
Glucocorticoid receptor modulators to treat pancreatic cancer
CORCEPT THERAPEUTICS INC1 citations72
US11590135B2Feb 28, 2023
Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonists
CORCEPT THERAPEUTICS INC1 citations71
US11944617B2Apr 2, 2024
Concomitant administration of glucocorticoid receptor modulator relacorilant and paclitaxel, a dual substrate of CYP2C8 and CYP3A4
CORCEPT THERAPEUTICS INC2 citations70
US11268145B2Mar 8, 2022
Methods for treating Cushing's syndrome
CORCEPT THERAPEUTICS INC3 citations70
US10604807B2Mar 31, 2020
Methods for diagnosing and assessing treatment for Cushing's syndrome
CORCEPT THERAPEUTICS INC3 citations70
US11542238B2Jan 3, 2023
Pyrimidine cyclohexenyl glucocorticoid receptor modulators
CORCEPT THERAPEUTICS INC5 citations69
US11787780B2Oct 17, 2023
Quaternary indazole glucocorticoid receptor antagonists
CORCEPT THERAPEUTICS INC3 citations67
US12171760B2Dec 24, 2024
Use of glucocorticoid receptor modulators to potentiate checkpoint inhibitors
CORCEPT THERAPEUTICS INC1 citations63
US12370175B2Jul 29, 2025
Glucocorticoid receptor modulators to treat pancreatic cancer
CORCEPT THERAPEUTICS INC0 citations62
US12139486B2Nov 12, 2024
Octahydro fused azadecalin glucocorticoid receptor modulators
CORCEPT THERAPEUTICS INC0 citations62
US12226417B2Feb 18, 2025
Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonists
CORCEPT THERAPEUTICS INC0 citations61
US12589094B2Mar 31, 2026
Concomitant administration of glucocorticoid receptor modulator relacorilant and paclitaxel, a dual substrate of CYP2C8 and CYP3A4
CORCEPT THERAPEUTICS INC0 citations60
US12180186B2Dec 31, 2024
Quaternary indazole glucocorticoid receptor antagonists
CORCEPT THERAPEUTICS INC0 citations57
US12018001B2Jun 25, 2024
Pyrimidine cyclohexenyl glucocorticoid receptor modulators
CORCEPT THERAPEUTICS INC0 citations57
US12226412B2Feb 18, 2025
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
CORCEPT THERAPEUTICS INC0 citations52
US11903945B2Feb 20, 2024
Methods of treating antipsychotic-induced weight gain with miricorilant
CORCEPT THERAPEUTICS INC0 citations44
US12433882B2Oct 7, 2025
Treatments for amyotrophic lateral sclerosis using dazucorilant
CORCEPT THERAPEUTICS INC0 citations42
CLARK ROBIN
1 patentCLARK ROBIN D
1 patentMONTANA JOHN
1 patentAVENTIS PHARMA INC
1 patentShowing the top 50 of 51 patents by PatentIndex Score.